After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Abeona Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Abeona Therapeutics Inc is $350.23M. A total of 0.4 million shares were traded on the day, compared to an average of 876.40K shares.
In the most recent transaction, Crombez Eric sold 4,718 shares of ABEO for 6.93 per share on Aug 14 ’25. After the transaction, the Director now owns 42,427 company shares. In a previous transaction on Aug 15 ’25, Vazzano Joseph Walter sold 15,000 shares at 7.36 per share. ABEO shares that Chief Financial Officer owns now total 462,666.
Among the insiders who bought shares, Vazzano Joseph Walter acquired of 15,000 shares on Aug 15 ’25 at a per-share price of $7.36. In another insider transaction, Vazzano Joseph Walter sold 1,502 shares at $6.64 per share on Jul 22 ’25. Company shares held by the Chief Financial Officer now total 477,666.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ABEO has a high of $7.54 and a low of $3.93.
As of this writing, ABEO has an earnings estimate of -$0.34 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.38. The company reported an EPS of -$0.31 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ABEO’s latest balance sheet shows that the firm has $45.02M in Cash & Short Term Investments as of fiscal 2021. There were $9.38M in debt and $16.62M in liabilities at the time. Its Book Value Per Share was $3.19, while its Total Shareholder’s Equity was $42.37M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABEO is Buy with a score of 5.00.
